Cypress Capital Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-33,364
Closed -$3.31M 247
2019
Q3
$3.31M Sell
33,364
-2,612
-7% -$248K 0.64% 49
2019
Q2
$3.33M Buy
35,976
+2,826
+9% +$268K 0.66% 52
2019
Q1
$3.13M Sell
33,150
-103
-0.3% -$9.01K 0.64% 51
2018
Q4
$2.13M Buy
33,253
+900
+3% +$66.4K 0.49% 63
2018
Q3
$2.9M Sell
32,353
-1,094
-3% -$96.7K 0.55% 61
2018
Q2
$2.66M Sell
33,447
-1,750
-5% -$145K 0.55% 62
2018
Q1
$3.14M Sell
35,197
-6,767
-16% -$650K 0.66% 56
2017
Q4
$4.38M Buy
41,964
+2,462
+6% +$278K 0.91% 31
2017
Q3
$5.76M Sell
39,502
-240
-0.6% -$32.7K 1.23% 24
2017
Q2
$5.16M Buy
39,742
+4,450
+13% +$545K 1.14% 25
2017
Q1
$4.39M Buy
35,292
+1,602
+5% +$192K 1.03% 31
2016
Q4
$3.9M Sell
33,690
-2,933
-8% -$327K 0.93% 35
2016
Q3
$3.83M Sell
36,623
-1,868
-5% -$202K 0.91% 37
2016
Q2
$3.8M Sell
38,491
-480
-1% -$49.7K 0.89% 41
2016
Q1
$3.9M Sell
38,971
-200
-0.5% -$20.6K 0.96% 38
2015
Q4
$4.69M Sell
39,171
-279
-0.7% -$32.3K 1.13% 33
2015
Q3
$4.27M Sell
39,450
-1,225
-3% -$152K 1.05% 34
2015
Q2
$4.71M Sell
40,675
-200
-0.5% -$22.9K 1.08% 32
2015
Q1
$4.71M Sell
40,875
-2,330
-5% -$278K 1.07% 34
2014
Q4
$4.83M Sell
43,205
-1,337
-3% -$141K 1.12% 30
2014
Q3
$4.22M Sell
44,542
-4,290
-9% -$387K 1% 34
2014
Q2
$4.19M Sell
48,832
-5,660
-10% -$430K 0.98% 33
2014
Q1
$3.8M Sell
54,492
-550
-1% -$43.6K 0.93% 35
2013
Q4
$4.65M Sell
55,042
-5,100
-8% -$404K 1.14% 27
2013
Q3
$4.63M Sell
60,142
-1,780
-3% -$125K 1.15% 30
2013
Q2
$3.62M Buy
+61,922
New +$3.73M 0.76% 51

Other funds holding CELG

Cypress Capital Group's CELG Position: Q4 2019 in Review

Cypress Capital Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 33,364 shares — an estimated $3.31M sold.

Cypress Capital Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $5.76M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Cypress Capital Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Cypress Capital Group sold 33,364 Celgene Corp shares in Q4 2019, an estimated $3.31M.
  • Cypress Capital Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Cypress Capital Group's Celgene Corp position peaked at $5.76M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Cypress Capital Group's 13F filing for Q4 2019, filed 10 Jan 2020.